- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Early Stage Non-small Cell Lung Cancer in Canada
Total 825 results
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaRecruitingNon-small Cell Lung Cancer | Metastasis From Other CancersCanada
-
Washington University School of MedicineNational Cancer Institute (NCI)RecruitingNon Small Cell Lung Cancer | Non-small Cell Lung CancerUnited States, Canada
-
Lawson Health Research InstituteTerminatedNon-small Cell Lung CancerCanada
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Ovarian Carcinoma | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Recurrent Non-Small Cell... and other conditionsCanada
-
PeriPharmJewish General Hospital; Personalized Medicine Partnership for CancerTerminatedNon-small Cell Lung Cancer MetastaticCanada
-
University Health Network, TorontoCompletedNon Small Cell Lung Cancer (NSCLC)Canada
-
AstraZenecaCompletedNon Small Cells Lung CancerQatar, Bahrain, United Arab Emirates
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedExtensive Stage Small Cel Lung CancerCanada
-
University Health Network, TorontoMount Sinai Hospital, CanadaCompletedNon Small Cell Lung CancerCanada
-
Canadian Cancer Trials GroupAstraZenecaCompletedNon Small Cell Lung CancerCanada
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom
-
Jewish General HospitalPfizer; PeriPharm; Quebec Clinical Research Organization in Cancer; Personalized...UnknownNon-small Cell Lung Cancer MetastaticCanada
-
AstraZenecaCompletedNon-small Cell Lung CancerCanada
-
Hoffmann-La RocheTerminatedSquamous Non-Small Cell Lung CancerCanada, Spain, Denmark
-
National Cancer Institute (NCI)CompletedExtensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung CancerCanada
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
University Health Network, TorontoRecruitingNon-small Cell CarcinomaCanada
-
Lawson Health Research InstituteActive, not recruiting
-
Bristol-Myers SquibbCompletedNon-small Cell Lung CancerCanada, United States
-
AHS Cancer Control AlbertaCross Cancer InstituteTerminatedNon-small Cell Lung Cancer | Advanced Solid MalignanciesCanada
-
British Columbia Cancer AgencyRecruitingNon Small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal MetastasisCanada
-
University Health Network, TorontoCompletedNon-small Cell Lung CancerCanada
-
British Columbia Cancer AgencySunnybrook Health Sciences Centre; AstraZeneca; Princess Margaret Hospital, CanadaRecruitingBrain Metastases | Lung Cancer Non-small Cell Stage IVCanada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatic Colorectal Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
Cell>Point LLCVenn Life Sciences; Numoda; Camargo Pharmaceutical Services; Biomedical ServicesCompletedNon Small Cell Lung CancerUnited States, Canada
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lunch CancerItaly, United States, Germany, Spain, Canada
-
Canadian Cancer Trials GroupOncolytics BiotechCompletedNon Small Cell Lung CancerCanada
-
AstraZenecaRecruiting
-
Peter MacCallum Cancer Centre, AustraliaCompletedNon-small Cell Lung CancerAustralia, Canada
-
Bristol-Myers SquibbNo longer availableNon-squamous Non-Small Cell Lung Cancer | Squamous Non-Small Cell Lung CancerBrazil, Canada
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Canada, France, Italy, Spain, United Kingdom, Belgium, Poland, Brazil, Germany, Hungary, Peru, Russian Federation, Turkey, Australia, Chile, Austria, Netherlands, Portugal, Israel, Mexico, Romania, Sweden, Ukraine, Bulgaria, Argenti...
-
Spanish Lung Cancer GroupCompletedNon-small-cell Lung CancerSpain
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedStage IV or Recurrent Non-Small Cell Lung CancerUnited States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
YM BioSciencesCIMYM BioSciencesTerminatedNon-small-cell Lung CancerCanada, United States, Singapore
-
Qu Biologics Inc.Completed
-
Millennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States, Netherlands, Canada
-
Spanish Lung Cancer GroupCompletedNon Small Cell Lung CancerSpain
-
Bristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States, Canada
-
Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term CareCompletedNon-small-cell Lung CarcinomaCanada
-
Fundación GECPActive, not recruiting
-
Toronto Sunnybrook Regional Cancer CentreOntario Clinical Oncology Group (OCOG); Ontario Cancer Research NetworkCompletedNon-Small Cell Lung CancerCanada
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerSpain, France, United States, Taiwan, Canada, Netherlands, Mexico
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small Cell | Non-Small-Cell Lung CancerUnited States, Canada, Poland
-
University Health Network, TorontoAstraZenecaWithdrawnSquamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaCanada
-
Achieve Life SciencesCompletedNon-small Cell Lung CancerUnited States, Canada
-
Synta Pharmaceuticals Corp.CompletedNon Small Cell Lung CancerUnited States, Canada
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
Lawson Health Research InstituteAcademic Medical Organization of Southwestern OntarioRecruitingNon-Small Cell Lung CancerCanada